# A Study of Xiongdan Wan Treating Depression

> **NCT05136365** · PHASE2 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 30 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Xiongdan Wan

## Key facts

- **NCT ID:** NCT05136365
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-28
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136365, "A Study of Xiongdan Wan Treating Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05136365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*